Evidence map›Paper›PMID 36431850›Full record

ArticleMolecules (Basel, Switzerland)2022

Phenol Derivatives Obtained from Grape Seed Extract Show Virucidal Activity against Murine Norovirus.

Vyankatesh Raml Kudkyal, Iori Matsuura, Hiroaki Hiramatsu, Kyoko Hayashi, Toshio Kawahara

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vyankatesh Raml KudkyalGraduate School of Engineering, Chubu University, Kasugai 487-8501, Japan.
Iori MatsuuraCollege of Life and Health Sciences, Chubu University, Kasugai 487-8501, Japan.
Hiroaki HiramatsuCollege of Life and Health Sciences, Chubu University, Kasugai 487-8501, Japan.
Kyoko HayashiCollege of Life and Health Sciences, Chubu University, Kasugai 487-8501, Japan.
Toshio KawaharaGraduate School of Engineering, Chubu University, Kasugai 487-8501, Japan.ORCID 0000-0003-0168-5825
Chubu University · JP

Funding

Japan Science and Technology Agency JPMJMI19D4Japan Science and Technology Agency JPMJMI22D2Japan Science and Technology Agency JPMJTR204HJapan Society for the Promotion of Science 22K04902
6 · The paper itself

Abstract

Human noroviruses are the most common pathogens known to cause acute gastroenteritis, a condition that can lead to severe illness among immunocompromised individuals such as organ transplant recipients and the elderly. To date, no safe and effective vaccines or therapeutic agents have been approved for treating norovirus infections. Therefore, we aimed to demonstrate the virucidal activity of grape seed extract (GSE), which contains >83% proanthocyanidins, against murine norovirus (MNV), a surrogate for human norovirus. GSE showed virucidal activity against MNV in a dose- and time-dependent manner. Atomic force microscopic analysis showed viral particle aggregates after treatment of MNV with GSE. MNV treated with 50 µg/mL of GSE for 10 min resulted in the absence of pathogenicity in an animal model of infection, indicating that GSE has irreversible virucidal activity against MNV particles. Thus, GSE may aid in the development of treatments for norovirus infections.

Indexed as

Caliciviridae InfectionsGrape Seed ExtractNorovirusAgedAnimalsHumansMicePhenolPhenolsGrape Seed ExtractPhenolPhenolsatomic force microscopygrape seed extractnorovirus infectionviral particle aggregationvirucidal activity

Identifiers

PMID36431850
PMCPMC9693041
OpenAlexW4308876457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.